Gå til innholdet
Menu

PHARMAQ acquires fish vaccination company Nordland Sett Vaks

 

Oslo, Norway
3 January 2017

PHARMAQ acquires fish vaccination company Nordland Sett Vaks
- Nordland Sett Vaks is a leading fish vaccination company renowned for its high quality vaccination machines and focus on innovation

• Acquisition will enable PHARMAQ to offer complete vaccination solutions
• PHARMAQ to support Nordland Sett Vaks’ international expansion

PHARMAQ, a business of Zoetis, today announced the acquisition of the Norwegian  company Nordland Sett Vaks, an innovator in the manufacture and marketing of high quality vaccination machinery for the aquaculture industry. Nordland Sett Vaks is based in Nesna, Norway and offers a wide range of fish vaccination services and sale of vaccination machines to fish farming companies in Norway, the UK and in the Mediterranean region. Terms of the transaction were not disclosed. 

“We have known Nordland Sett Vaks for a long time, and we have been very impressed with their high focus on quality and innovative solutions. We are delighted to start working even closer together with Nordland Sett Vaks and to support the company’s international expansion”, says Morten Nordstad, President of PHARMAQ.

Nordland Sett Vaks was established in 1995, and it is today a leading machine fish vaccination company. Nordland Sett Vaks offers machine fish vaccination services and vaccination machines for a variety of different fish species in several markets.
“We believe PHARMAQ is the perfect partner to support our growth plans” says the Founders of Nordland Sett Vaks, Jørn Ståle Pettersen and Remy Kristian Oddøy, who both will continue to lead the company as part of PHARMAQ.

“Nordland Sett Vaks will enable PHARMAQ to offer complete vaccination solutions to our customers all over the world, and we furthermore believe that safe and efficient vaccination services will help increase the adoption of the use of vaccines in several markets” says Svein Alexandersen, Senior Manager Customer Service for Norway and Nordics in PHARMAQ.

For further information, please contact:
Morten Nordstad, President PHARMAQ a business of Zoetis
Mobile: +47 907 52 853

Jørn Ståle Pettersen, Founder of Nordland Sett Vaks
Mobile: +47 900 71726


About PHARMAQ

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 200 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.com

About Zoetis
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2015, the company generated annual revenue of $4.8 billion with approximately 9,000 employees. For more information, visit www.zoetis.com .

DISCLOSURE NOTICES
Forward-Looking Statements: This press release contains forward-looking statements, which reflect the current views of Zoetis with respect to business plans or prospects, future operating or financial performance, future guidance, future operating models, expectations regarding products, future use of cash and dividend payments, tax rate and tax regimes, changes in the tax regimes and laws in other jurisdictions, and other future events. These statements are not guarantees of future performance or actions. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management's underlying assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Forward-looking statements speak only as of the date on which they are made. Zoetis expressly disclaims any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. A further list and description of risks, uncertainties and other matters can be found in our Annual Report on Form 10-K for the fiscal year ended December 31, 2015, including in the sections thereof captioned “Forward-Looking Information and Factors That May Affect Future Results” and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and in our Current Reports on Form 8-K. These filings and subsequent filings are available online at www.sec.gov, www.zoetis.com, or on request from Zoetis. 

Did you know...

WE MAKE AQUACULTURE PROGRESS

Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.

»
»
»
»
»
»
»
»
»
»

Norway

PHARMAQ AS
Head office/
Production facility
Skogmo Industriområde
Industrivegen 50
N-7863 Overhalla, Norway
Tel:+47 74 28 08 00
customer.service​@pharmaq.no


PHARMAQ AS
Production facility
Dyrskuevien 13, 2040 Kløfta
P.O.Box 152, N-2041 Kløfta, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ AS
Harbitzalléen 2A, 0275 Oslo
P.O.Box 267 Skøyen
N-0213 Oslo, Norway
Tel: +47 23 29 85 00
customer.service​@pharmaq.no

   

PHARMAQ Analytiq
Thormøhlensgate 53D
N-5008 Bergen, Norway
Tel: (+47) 23 29 85 00
kontakt@analytiq.no

   

PHARMAQ Fishteq
Havneveien 6
N-8700 Nesna, Norway
Tel:+47 941 63 150
PHQ.fishteqsupport@zoetis.com

Chile

PHARMAQ AS Chile Ltda.
Bernardino # 1981, Piso 2, Oficina 202,
Parque Empresarial San Andrés,
Puerto Montt, Chile
Tel: +56 65 248 3091
customer.service​@pharmaq.no

 

United Kingdom

PHARMAQ Ltd.
Unit 15 Sandleheath Industrial Estate,
Fordingbridge,
Hampshire SP6 1PA,
United Kingdom
Tel: +44 1425 656081
orders@pharmaq.no

Terms & Conditions of Purchase
Terms & Conditions of Sale
Tax strategy and Disclosure: Financial year ending 30 November 2017

Turkey

PHARMAQ Veteriner Ecza Deposu ve Su Ürünleri Tic.Ltd.Şti
KARACAOGLAN MAH. 6166 SK. 21 A BORNOVA/ IZMIR Turkiye
Tel: +90 232 422 23 10
customer.service​@pharmaq.no

Vietnam

PHARMAQ Ltd. VN
R. 2503, 25th Fl., Viettel Tower
285 Cach Mang Thang Tom
W.12, D10, HCMC, Vietnam
Tel : +84 28 6284 5350
customer.service​@pharmaq.no

Panama

Zoetis Panamá / PHARMAQ Panamá
Piso 2. Oficina 108. P.H. Albrook Commercial Park
Ave. Bella Vista, Ancón, Panamá
PO. Box: 0832-0588
Phone: +507 3215363
Mob.: +507 6675 1109
customer.service​@pharmaq.no

Spain

PHARMAQ Spain Aqua
Avda de Europa 20B
Parque Empresarial La Moraleja
28108 Alcobendas, Spain
Tel: +34 91 419 19 35
customer.service​@pharmaq.no

Singapore

PHARMAQ part of Zoetis
108 Pasir Panjang Road
Singapore 118535, Singapore
Tel.: +65 6933 5800
customer.service​@pharmaq.no

PHARMAQ is the global leader in vaccines and innovation for aquaculture and part of Zoetis, the world leader in animal health. The company provides environmentally sound, safe and efficacious health products to the global aquaculture industry through targeted research and the commitment of dedicated people. Production facilities, administration and research and development activities are based in Norway with subsidiaries in Chile, United Kingdom, Vietnam, Turkey, Spain, Panama and Hong Kong. PHARMAQ has approximately 300 employees. The company's products are marketed in Europe, North and South America, and Asia. For further information, visit the company's website at www.pharmaq.comPrivacy Policy. Cookie Policy. Terms of Use.

Copyright © 2016 Zoetis LLC. All rights reserved.

Utviklet av Imaker as